Who Paid My Doc
Marta Fernandez
General Practice Hollywood, FL Medical Doctor
NPI 1780666750 CMS profile 528148
7900 Nw 33Rd St Ste 101, Hollywood, FL 33024
General payments
$1,927
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$5,481,612
Through program year 2023, Marta Fernandez of Hollywood, FL is reported in the CMS Open Payments database as having received $1,927 across 93 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,481,612 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 87th percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $19 | 1 | |
| 2022 | General | $324 | 6 | |
| 2021 | General | $669 | 29 | |
| 2020 | General | $646 | 40 | |
| 2019 | General | $269 | 17 |
Beside peers
- Marta Fernandez
- General Practice median
- Middle half of General Practice
- National median
In program year 2025, general payments to Marta Fernandez were reported at $0. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.
Show as a table
| Year | Marta Fernandez | General Practice median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $269 | $107 | $37–$285 | $163 |
| 2020 | $646 | $75 | $25–$213 | $114 |
| 2021 | $669 | $93 | $30–$272 | $132 |
| 2022 | $324 | $103 | $36–$279 | $149 |
| 2023 | $19 | $106 | $34–$276 | $160 |
| 2024 | $0 | $114 | $39–$290 | $164 |
| 2025 | $0 | $106 | $35–$292 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 46 drugsPart D claims
1,334
Drug cost
$17,105
Branded share of claims
13%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Mupirocin Mupirocin Calcium | Brand | 11 | $3,242 | |
| Diclofenac Sodium | Generic | 65 | $2,326 | |
| Ezetimibe | Generic | 61 | $1,280 | |
| Clobetasol Propionate | Generic | 15 | $1,133 | |
| Gabapentin | Generic | 49 | $1,096 | |
| Rosuvastatin Calcium | Generic | 67 | $702 | |
| Atorvastatin Calcium | Generic | 74 | $664 | |
| Metoprolol Succinate | Generic | 22 | $487 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 24 | $444 | |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | Brand | 17 | $402 |
The 10 drugs with the highest cost, of 46 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$7,074
Medicare patients
25
Services billed
95
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 68% | |
| Arthritis | 52% | |
| Chronic kidney disease | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
93 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other General Practice in Florida
Caley Castelein
General Practice · Miami Beach, FL
Robert Althar
General Practice · Pensacola, FL
Florencia Ziemke
General Practice · West Palm Beach, FL
Ausberto Hidalgo
General Practice · Pembroke Pines, FL
Ernesto Lamadrid
General Practice · Gainesville, FL
Idalia Acosta
General Practice · Miami, FL
Related records
General Practice in Florida
Practitioners in the same specialty and state, ranked by reported value.
All General Practice
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.